Venezuelan Equine Encephalitis virus (VEEV) is a mosquito‑borne alphavirus in the Togaviridae family that causes febrile and neuroinvasive disease in horses and humans across Central and South America. Epizootic strains can spark large epidemics and severe equine mortality.
Epidemiology and Virology
VEEV has a single‑stranded positive‑sense RNA genome enclosed in an icosahedral nucleocapsid and a lipid envelope. It belongs to the Venezuelan equine encephalitis complex, which includes multiple antigenic subtypes and varieties. Enzootic strains (e.g., subtype ID and varieties II–VI) circulate in forested and swamp habitats of Central and South America and the Caribbean, where they are maintained in cycles involving rodents and Culex (Melanoconion) mosquitoes. These strains typically cause mild human disease. Epizootic subtypes IAB and IC emerge when mutations enable efficient infection of equids, leading to amplification in horses and donkeys and high‑titer viremia that facilitates transmission to humans by bridge vectors such as Aedes and Psorophora. Horses and humans are incidental hosts for enzootic strains but amplification hosts during epizootics. VEEV was first isolated from a horse in 1938 during an outbreak in Venezuela, and subsequent epidemics have occurred in Colombia, Peru, Ecuador, Mexico and the United States. There is no licensed human vaccine; attenuated and inactivated vaccines are available for equines and laboratory personnel.
Outbreaks and Clinical Features
VEEV infection typically presents after an incubation period of 2–5 days with abrupt onset of fever, chills, severe headache, myalgia and malaise. Nausea, vomiting and photophobia are common. Most patients recover without complications, but children are at higher risk of neuroinvasive disease, which may include seizures, ataxia and encephalitis. Mortality in human cases is usually below 1%, but neurologic sequelae can occur. In equids, VEEV causes high fever, depression and progressive neurologic signs culminating in recumbency and death; mortality can exceed 50% during epizootics. Large outbreaks were recorded in the 1930s and 1960s, with the 1969‑1972 pandemic spreading from Ecuador and Peru through Central America to Texas, causing thousands of equine deaths and tens of thousands of human cases. Control strategies include vaccination of equines, surveillance of rodent and mosquito populations, and vector control through insecticides and habitat modification. Personal protective measures reduce human exposure in endemic regions. Venezuelan Equine Encephalitis virus illustrates how genetic variation and ecological conditions drive the emergence of arboviral epidemics. Although epizootics are sporadic, ongoing surveillance, vaccination of equids and mosquito control remain essential for preventing disease in humans and animals. Related Terms: Eastern equine encephalitis virus, Western equine encephalitis virus, Mayaro virus, Chikungunya virus, Alphavirus